EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case report: Sodium-glucose cotransporter 2 inhibitors induce left ventricular reverse remodeling in anthracycline-related cardiac dysfunction—a case series

Francesco Giangiacomi, Andrea Faggiano, Daniela Cardinale, Francesca Gaia Rossi, Alberto Pollina, Elisa Gherbesi, Eleonora Gnan, Stefano Carugo, Marco Vicenzi

Frontiers in Cardiovascular Medicine · 22.08.2023 · 10

DOI: 10.3389/fcvm.2023.1250185 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Cardiovascular Medicine, online erschienen am 22.08.2023. Verfasst von Francesco Giangiacomi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To describe the efficacy and safety of sodium-glucose cotransporter 2 inhibitors as a specific treatment for anthracycline-related cardiac dysfunction in a small real-world population.

Methods

Seven patients with anthracycline-related cardiac dysfunction were clinically and echocardiographically evaluated before and after the introduction of sodium-glucose cotransporter 2 inhibitors.

Results

After a median period of 24 weeks with uninterrupted sodium-glucose cotransporter 2 inhibitors treatment, a significant clinical improvement was observed with at least one New York Heart Association Functional Class (NHYA FC) improvement in all patients (median NYHA FC: I vs. III, p < 0.010). A noteworthy left ventricular reserve remodeling (median left ventricular end diastolic volume indexed: 53 vs. 82.5 ml/m 2 , p = 0.018; median left ventricular ejection fraction: 50% vs. 40%, p = 0.17) was also observed. Sodium-glucose cotransporter 2 inhibitors therapy was well tolerated by every patients; no cases of discontinuation or relevant side effects were observed.

Conclusion

Sodium-glucose cotransporter 2 inhibitors induce a significant clinical improvement and left ventricular reserve remodeling in patients affected by anthracycline-related cardiac dysfunction.

Schlagwörter

Stichwörter der Autor:innen

anthracycline-related cardiac dysfunctioncardiotoxicityheart faillureleft ventricular remodelingsodium-glucose cotransporter 2 inhibitors

Autor:innen und Institutionen

  • Department of Cardio-Thoracic-Vascular Diseases, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Dyspnea Lab, Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy.
  • Cardioncology Unit, European Institute of Oncology, IRCCS, Milan, Italy.
  • Haematology Unit, Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.

Zitieren

APA

Giangiacomi, F., Faggiano, A., Cardinale, D., Rossi, F. G., Pollina, A., Gherbesi, E., Gnan, E., Carugo, S., & Vicenzi, M. (2023). Case report: Sodium-glucose cotransporter 2 inhibitors induce left ventricular reverse remodeling in anthracycline-related cardiac dysfunction—a case series. Frontiers in Cardiovascular Medicine, 10. https://doi.org/10.3389/fcvm.2023.1250185

Vancouver

Giangiacomi F, Faggiano A, Cardinale D, Rossi FG, Pollina A, Gherbesi E, et al. Case report: Sodium-glucose cotransporter 2 inhibitors induce left ventricular reverse remodeling in anthracycline-related cardiac dysfunction—a case series. Frontiers in Cardiovascular Medicine. 2023;10. doi:10.3389/fcvm.2023.1250185

BibTeX
@article{Giangiacomi2023,
  author = {Giangiacomi, Francesco and Faggiano, Andrea and Cardinale, Daniela and Rossi, Francesca Gaia and Pollina, Alberto and Gherbesi, Elisa and Gnan, Eleonora and Carugo, Stefano and Vicenzi, Marco},
  title = {Case report: Sodium-glucose cotransporter 2 inhibitors induce left ventricular reverse remodeling in anthracycline-related cardiac dysfunction—a case series},
  journal = {Frontiers in Cardiovascular Medicine},
  year = {2023},
  volume = {10},
  doi = {10.3389/fcvm.2023.1250185}
}
Kostenlos starten →